Synagis Coupons & Savings Card – Discount Prices from $1881.84
My prescription
Edit
0.5ML of 50MG/0.5ML, Synagis (1 Vial)
Select pharmacy
Walgreens
$1881.84
COUPON PRICESynagis savings card
Show this card to your pharmacistWalgreens
$1881.84
BIN
ID
PCN
GRP
019876
LHF154519C
CHIPPO
LHX
Powered by
Related monoclonal antibodies prescriptions
More prescriptions for lower respiratory infection
Related monoclonal antibodies prescriptions
More prescriptions for lower respiratory infection
Price history for Synagis
1 Vial, 0.5ML of 50MG/0.5ML
Average retail price for Synagis
Average SaveHealth price for Synagis
Our price history data is based on aggregated prescription data collected from participating pharmacies in America. Our prescription data updates daily to reflect the latest price changes. If you notice a missing data point, it means there wasn't sufficient data available to generate a monetary value for that date.
*Retail prices are based on pharmacy claims data, and may not be accurate when we don't have enough claims.
Synagis dosage forms
| Dosage | Quantity | Price from | Per unit |
|---|---|---|---|
| 0.5ML of 50MG/0.5ML | 1 Vial | $1881.84 | $1881.84 |
| 1ML of 100MG/ML | 1 Vial | $3560.56 | $3560.56 |
Synagis Warnings
The safety information provided here outlines crucial warnings and precautions related to the use of Synagis (palivizumab). Carefully consider these points and discuss any concerns with your healthcare provider to ensure the safe administration of this medication.
Severe Allergic Reactions: Synagis (palivizumab) can cause serious allergic reactions in some children. Symptoms may include hives, itching, sudden blood pressure drops, breathing difficulties, and swelling of the face and throat. These reactions can occur with the initial or subsequent doses. If your child experiences such a reaction, they must not receive Synagis (palivizumab) again.
Bleeding Concerns: Since Synagis (palivizumab) is administered via an injection into the muscle, it is important to exercise caution if your child has a history of low platelet counts or bleeding disorders. Discuss any history of clotting issues with your healthcare provider before proceeding with treatment.
Not a Treatment for RSV: Synagis (palivizumab) is approved only for the prevention of Respiratory Syncytial Virus (RSV) and not as a treatment. Even if your child contracts RSV, continue the monthly doses as recurring infections can occur within the same season.
Contraindications: Synagis (palivizumab) should not be used if a serious allergic reaction to it has occurred previously. Consult with your healthcare provider if this applies to your child.
Always consult your healthcare provider for more information and guidance tailored to your child's specific health needs.
Synagis Side Effects
When taking this medication, some individuals may experience mild side effects such as fever or rash. Fever is reported in about 27% of cases, while rash occurs in around 12% of users. Additionally, reactions at the injection site, including pain, redness, and swelling, are common but generally not a cause for concern. If these mild effects persist or worsen, it’s advisable to consult a healthcare provider for guidance. On rare occasions, a serious allergic reaction may occur, which requires immediate medical attention. Symptoms of such an allergic reaction include hives, itching, a sudden drop in blood pressure, difficulty breathing, bluish skin, and swelling of the face or throat. These symptoms are significant and should not be ignored. If you experience any of these severe side effects, seek urgent medical care promptly. Always be attentive to how your body responds to the medication and report any unusual or severe symptoms to your healthcare provider. While the majority of users do not experience serious side effects, staying informed and vigilant is important for your health and safety.
Synagis Interactions
Is SYNAGIS still being used?
Yes, Synagis (palivizumab) is still being used. It is a medication given to help prevent serious lung disease caused by respiratory syncytial virus (RSV) in certain high-risk infants and young children.
How much does SYNAGIS cost?
The cost of SYNAGIS can vary significantly based on factors such as the pharmacy, location, insurance coverage, and dosage required. It is recommended to contact a local pharmacy or healthcare provider for the most accurate and up-to-date pricing information. Additionally, insurance plans may cover part or all of the cost, so checking with the insurance provider is advisable.
How much does palivizumab cost in the US?
The cost of palivizumab in the US can vary depending on factors such as the pharmacy, location, and insurance coverage. On average, the price for a single dose can range from $1,500 to $3,000. It is important for individuals to check with their healthcare provider or insurance company for specific pricing and coverage details.
Is Synagis still given?
Yes, Synagis (palivizumab) is still administered. It is used to help prevent serious lung disease caused by respiratory syncytial virus (RSV) in certain high-risk infants and young children.
How much is SYNAGIS out of pocket?
The out-of-pocket cost for SYNAGIS can vary significantly depending on factors such as insurance coverage, location, and pharmacy pricing. Without insurance, SYNAGIS can be quite expensive, often costing several thousand dollars per dose. Patients are encouraged to check with their insurance provider for coverage details and to inquire about any available assistance programs that may help reduce the cost.